News

As much of the world moves on from the early chaos of the pandemic, a new COVID-19 variant is quietly making its way through ...
Health officials are tracking a highly contagious new COVID-19 variant. This comes as confusion grows over vaccine ...
Health officials are tracking a new COVID-19 variant. This comes as confusion grows over vaccine recommendations moving ...
A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...
Objective To determine distinct patterns of patients with autoimmune diseases harbouring anti-Ku antibodies and their respective prognosis.Methods Anti-Ku-positive patients were retrieved through four ...
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...
Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.
Pericarditis refers to inflammation ... who were diagnosed with COVID-19 vaccine-associated myocarditis, 89 reported cardiac symptoms after about 91 days. Forshee said one of the study’s ...
For those who experienced symptoms like heart inflammation ... to the Pfizer and Moderna labels about the risk of myocarditis and pericarditis. But by then, millions of people — including ...